ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 51 filers reported holding ENZO BIOCHEM INC in Q4 2013. The put-call ratio across all filers is 16.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,609,000 | +33.6% | 1,528,737 | -2.0% | 0.00% | +100.0% |
| Q3 2016 | $7,942,000 | -18.3% | 1,560,324 | -4.2% | 0.00% | -50.0% |
| Q2 2016 | $9,723,000 | +62.7% | 1,628,583 | +24.0% | 0.00% | +100.0% |
| Q1 2016 | $5,976,000 | +6.7% | 1,313,472 | +5.5% | 0.00% | 0.0% |
| Q4 2015 | $5,602,000 | +40.4% | 1,244,816 | -1.1% | 0.00% | 0.0% |
| Q3 2015 | $3,990,000 | +5.3% | 1,258,723 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $3,788,000 | -16.0% | 1,250,007 | -18.3% | 0.00% | 0.0% |
| Q1 2015 | $4,512,000 | -31.0% | 1,529,448 | +3.9% | 0.00% | 0.0% |
| Q4 2014 | $6,538,000 | -12.9% | 1,472,443 | +1.1% | 0.00% | 0.0% |
| Q3 2014 | $7,504,000 | +1.4% | 1,457,071 | +3.4% | 0.00% | 0.0% |
| Q2 2014 | $7,400,000 | +62.2% | 1,409,537 | +28.5% | 0.00% | 0.0% |
| Q1 2014 | $4,563,000 | +77.1% | 1,096,938 | +24.3% | 0.00% | – |
| Q4 2013 | $2,576,000 | +30.1% | 882,157 | +12.3% | 0.00% | – |
| Q3 2013 | $1,980,000 | +9.8% | 785,595 | -9.4% | 0.00% | – |
| Q2 2013 | $1,803,000 | – | 866,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
| CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
| KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
| First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
| Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
| MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
| Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
| EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
| ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |